Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

24
Number of overlapping holdings
49.0%
% of PINK's 53 holdings also in XLV
40.0%
% of XLV's 60 holdings also in PINK
Overlap by Weight
Sector Drift (PINK minus XLV)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in PINK |
Weight in XLV |
Overlap | |
---|---|---|---|---|
ELI LILLY & CO | 10.1% | 12.3% | 10.1% | |
ABBVIE INC | 5.2% | 6.9% | 5.2% | |
JOHNSON & JOHNSON | 5.0% | 7.5% | 5.0% | |
UNITEDHEALTH GROUP INC | 4.9% | 9.0% | 4.9% | |
THERMO FISHER SCIENTIFIC INC | 3.3% | 3.6% | 3.3% |
Position Highlights (Non-Overlapping Exposures)
PINK Overweight Relative to XLV
ARCUTIS BIOTHERAPEUTICS INC | 7.6% | |
REGENERON PHARMACEUTICALS | 5.3% | |
RESMED INC | 4.3% | |
PACIRA PHARMACEUTICALS INC | 3.1% | |
PURECYCLE TECHNOLOGIES INC | 3.1% | |
DANAHER CORP | 2.7% | |
GILEAD SCIENCES INC | 2.3% | |
CARDINAL HEALTH INC | 1.9% | |
SANOFI-AVENTIS-ADR | 1.7% | |
ADMA BIOLOGICS, INC. | 1.7% |
PINK Underweight Relative to XLV
MERCK & CO. INC. | -4.3% | |
UNITEDHEALTH GROUP INC | -4.1% | |
AMGEN INC | -3.1% | |
BOSTON SCIENTIFIC CORP | -2.7% | |
PFIZER INC | -2.7% | |
JOHNSON & JOHNSON | -2.5% | |
BRISTOL-MYERS SQUIBB CO | -2.3% | |
ABBOTT LABORATORIES | -2.2% | |
ELI LILLY & CO | -2.1% | |
MEDTRONIC PLC | -2.1% |